Stock Research for NSPR

NSPR

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

NSPR Stock Chart & Research Data

The NSPR chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the NSPR chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


NSPR Due diligence Resources & Stock Charts

The NSPR stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View NSPR Detailed Price Forecast - CNN Money CNN View NSPR Detailed Summary - Google Finance
Yahoo View NSPR Detailed Summary - Yahoo! Finance Zacks View NSPR Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View NSPR Trends & Analysis - Trade-Ideas Barrons View NSPR Major Holders - Barrons
NASDAQ View NSPR Call Transcripts - NASDAQ Seeking View NSPR Breaking News & Analysis - Seeking Alpha
Spotlight View NSPR Annual Report - CompanySpotlight.com OTC Report View NSPR OTC Short Report - OTCShortReport.com
TradeKing View NSPR Fundamentals - TradeKing Charts View NSPR SEC Filings - Bar Chart
WSJ View Historical Prices for NSPR - The WSJ Morningstar View Performance/Total Return for NSPR - Morningstar
MarketWatch View the Analyst Estimates for NSPR - MarketWatch CNBC View the Earnings History for NSPR - CNBC
StockMarketWatch View the NSPR Earnings - StockMarketWatch MacroAxis View NSPR Buy or Sell Recommendations - MacroAxis
Bullish View the NSPR Bullish Patterns - American Bulls Short Pains View NSPR Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View NSPR Stock Mentions - StockTwits PennyStocks View NSPR Stock Mentions - PennyStockTweets
Twitter View NSPR Stock Mentions - Twitter Invest Hub View NSPR Investment Forum News - Investor Hub
Yahoo View NSPR Stock Mentions - Yahoo! Message Board Seeking Alpha View NSPR Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for NSPR - SECform4.com Insider Cow View Insider Transactions for NSPR - Insider Cow
CNBC View NSPR Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for NSPR - OTC Markets
Yahoo View Insider Transactions for NSPR - Yahoo! Finance NASDAQ View Institutional Holdings for NSPR - NASDAQ


Stock Charts

FinViz View NSPR Stock Insight & Charts - FinViz.com StockCharts View NSPR Investment Charts - StockCharts.com
BarChart View NSPR Stock Overview & Charts - BarChart Trading View View NSPR User Generated Charts - Trading View




Latest Financial News for NSPR


InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference
Posted on Wednesday April 03, 2024

TEL AVIV, Israel and MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that Marvin Slosman, Chief Executive Officer, will deliver a company update presentation at the 23rd Annual Needham Virtual Healthcare Conference, which is being held April 8-11, 2024. Presentation details: Date:Wednesday, April 10th Time:8:00-8:40 AM ET Webcast:https://wsw.com/webcast/needham13


InspireMD's (NASDAQ:NSPR) investors will be pleased with their solid 110% return over the last year
Posted on Sunday March 31, 2024

It hasn't been the best quarter for InspireMD, Inc. ( NASDAQ:NSPR ) shareholders, since the share price has fallen 16...


InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024
Posted on Tuesday March 26, 2024

TEL AVIV, Israel and MIAMI, March 26, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that an abstract of the one-year outcomes from its C-GUARDIANS IDE clinical trial of the CGuard™ Prime Carotid Stent System for the treatment of carotid artery stenosis has been accepted for presentation at the Leipzig Interventional Course (LINC) 2024, which is being held May 28-31, in Leipzig,


InspireMD, Inc. (NASDAQ:NSPR) Q4 2023 Earnings Call Transcript
Posted on Thursday March 07, 2024

InspireMD, Inc. (NASDAQ:NSPR) Q4 2023 Earnings Call Transcript March 6, 2024 InspireMD, Inc. beats earnings expectations. Reported EPS is $-0.16, expectations were $-0.2. InspireMD, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings. Welcome to InspireMD Fourth Quarter and […]


Stock Market & Investing Books

Enter a stock symbol to view the stock details.